Ms. Hamutal Yitzhak: Early Warning Report Filed Pursuant to National Instrument 62-103 Filer"), Chief Executive Officer and a director of Else Nutrition Holdings Inc. (the " Issuer"), in respect of her decreased holdings of the outstanding common shares (each, a " Share") in the capital of the Issuer by more than 2%. This report is an update to a previously filed early warning report dated June 15, 2020 (the " Prior Report"). Effective December 14, 2020, the Filer ceased to exercise voting control or direction (the " Deemed Disposition") over an aggregate of 599,995 Shares, pursuant to the voting support agreements more particularly described in the Prior Report. The Deemed Disposition represented a decrease of less than 2% of the 94,567,672 Shares currently outstanding. However, when taken together with the additional number of Shares issued by the Issuer from treasury since the date of the Prior Report, resulting in general dilution to shareholders, the Filer's holdings in the Share class decreased from approximately 19.63%, as of the Prior Report, to approximately 16.20% of the current outstanding Shares. This represents an overall decrease of approximately 3.63%, on a partially-diluted basis, since the Prior Report, assuming the exercise of 292,361 stock options to acquire Shares (each, an "